Genesys International Corporation Limited Logo

Genesys International Corporation Limited

GENESYS.NS

(2.0)
Stock Price

777,35 INR

0.42% ROA

3.09% ROE

1367.58x PER

Market Cap.

18.889.173.675,00 INR

8.84% DER

0% Yield

5.4% NPM

Genesys International Corporation Limited Stock Analysis

Genesys International Corporation Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Genesys International Corporation Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (17.7%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

5 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (9.832), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

6 ROA

The stock's ROA (0%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Genesys International Corporation Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Genesys International Corporation Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Genesys International Corporation Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Genesys International Corporation Limited Revenue
Year Revenue Growth
2006 192.307.816
2007 472.845.087 59.33%
2008 835.419.441 43.4%
2009 742.857.763 -12.46%
2010 950.651.568 21.86%
2011 959.872.089 0.96%
2012 1.137.493.665 15.62%
2013 751.179.139 -51.43%
2014 602.655.129 -24.64%
2015 469.557.201 -28.35%
2016 766.810.056 38.76%
2017 1.137.673.553 32.6%
2018 1.147.309.448 0.84%
2019 1.054.468.000 -8.8%
2020 795.588.000 -32.54%
2021 1.165.103.000 31.72%
2022 1.811.285.000 35.68%
2023 1.327.508.000 -36.44%
2023 1.982.429.000 33.04%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Genesys International Corporation Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Genesys International Corporation Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 83.604.466 100%
2013 50.800.276 -64.57%
2014 0 0%
2015 0 0%
2016 0 0%
2017 39.108.731 100%
2018 21.153.071 -84.88%
2019 26.703.000 20.78%
2020 33.508.000 20.31%
2021 36.961.000 9.34%
2022 81.610.000 54.71%
2023 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Genesys International Corporation Limited EBITDA
Year EBITDA Growth
2006 41.733.475
2007 183.022.344 77.2%
2008 351.231.993 47.89%
2009 417.224.250 15.82%
2010 558.043.392 25.23%
2011 438.464.337 -27.27%
2012 328.287.584 -33.56%
2013 172.513.604 -90.3%
2014 150.847.033 -14.36%
2015 130.916.425 -15.22%
2016 295.436.929 55.69%
2017 418.647.118 29.43%
2018 220.382.748 -89.96%
2019 168.779.000 -30.57%
2020 -1.731.000 9850.38%
2021 307.179.000 100.56%
2022 651.915.000 52.88%
2023 352.612.000 -84.88%
2023 855.651.000 58.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Genesys International Corporation Limited Gross Profit
Year Gross Profit Growth
2006 192.307.816
2007 472.845.087 59.33%
2008 835.419.441 43.4%
2009 742.857.763 -12.46%
2010 950.651.568 21.86%
2011 959.872.089 0.96%
2012 1.036.566.899 7.4%
2013 304.206.675 -240.74%
2014 296.200.843 -2.7%
2015 175.770.891 -68.52%
2016 395.930.696 55.61%
2017 540.043.233 26.69%
2018 382.106.687 -41.33%
2019 255.353.000 -49.64%
2020 169.140.000 -50.97%
2021 358.423.000 52.81%
2022 777.378.000 53.89%
2023 491.760.000 -58.08%
2023 989.361.000 50.3%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Genesys International Corporation Limited Net Profit
Year Net Profit Growth
2006 21.355.479
2007 149.865.902 85.75%
2008 309.836.007 51.63%
2009 326.913.258 5.22%
2010 460.312.578 28.98%
2011 164.459.310 -179.89%
2012 206.212.853 20.25%
2013 68.357.536 -201.67%
2014 45.758.960 -49.39%
2015 22.190.095 -106.21%
2016 159.354.349 86.07%
2017 170.057.370 6.29%
2018 -37.320.927 555.66%
2019 -50.855.000 26.61%
2020 -517.882.000 90.18%
2021 134.115.000 486.15%
2022 190.778.000 29.7%
2023 -132.084.000 244.44%
2023 220.729.000 159.84%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Genesys International Corporation Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 1
2007 6 100%
2008 11 45.45%
2009 11 -10%
2010 16 33.33%
2011 6 -200%
2012 7 16.67%
2013 2 -200%
2014 1 -100%
2015 1 0%
2016 5 100%
2017 6 0%
2018 -1 600%
2019 -2 0%
2020 -17 93.75%
2021 4 500%
2022 5 20%
2023 -3 266.67%
2023 6 160%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Genesys International Corporation Limited Free Cashflow
Year Free Cashflow Growth
2006 128.757.433
2007 -27.590.163 566.68%
2008 366.518.187 107.53%
2009 20.652.464 -1674.69%
2010 33.382.820 38.13%
2011 366.978.682 90.9%
2012 271.294.464 -35.27%
2013 4.521.009 -5900.75%
2014 -43.332.832 110.43%
2015 368.860.959 111.75%
2016 -25.542.076 1544.13%
2017 -353.545.160 92.78%
2018 -527.187.422 32.94%
2019 182.591.000 388.73%
2020 122.062.000 -49.59%
2021 49.538.000 -146.4%
2022 -1.331.538.000 103.72%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Genesys International Corporation Limited Operating Cashflow
Year Operating Cashflow Growth
2006 136.446.797
2007 48.408.511 -181.87%
2008 504.594.248 90.41%
2009 53.688.728 -839.85%
2010 344.508.722 84.42%
2011 407.196.644 15.39%
2012 349.452.076 -16.52%
2013 72.387.839 -382.75%
2014 11.446.043 -532.43%
2015 446.051.515 97.43%
2016 -6.628.651 6829.14%
2017 167.360.027 103.96%
2018 -229.636.875 172.88%
2019 296.921.000 177.34%
2020 288.315.000 -2.98%
2021 274.780.000 -4.93%
2022 -351.919.000 178.08%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Genesys International Corporation Limited Capital Expenditure
Year Capital Expenditure Growth
2006 7.689.364
2007 75.998.674 89.88%
2008 138.076.061 44.96%
2009 33.036.264 -317.95%
2010 311.125.902 89.38%
2011 40.217.962 -673.6%
2012 78.157.612 48.54%
2013 67.866.830 -15.16%
2014 54.778.875 -23.89%
2015 77.190.556 29.03%
2016 18.913.425 -308.13%
2017 520.905.187 96.37%
2018 297.550.547 -75.06%
2019 114.330.000 -160.26%
2020 166.253.000 31.23%
2021 225.242.000 26.19%
2022 979.619.000 77.01%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Genesys International Corporation Limited Equity
Year Equity Growth
2006 260.371.464
2007 375.633.199 30.68%
2008 703.919.555 46.64%
2009 988.297.278 28.77%
2010 1.408.818.503 29.85%
2011 1.553.906.482 9.34%
2012 1.751.389.311 11.28%
2013 2.015.381.835 13.1%
2014 2.082.033.833 3.2%
2015 2.141.687.445 2.79%
2016 2.282.856.842 6.18%
2017 2.248.224.211 -1.54%
2018 3.156.203.695 28.77%
2019 3.061.256.000 -3.1%
2020 2.549.311.000 -20.08%
2021 2.358.727.000 -8.08%
2022 4.074.868.000 42.12%
2023 4.023.409.000 -1.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Genesys International Corporation Limited Assets
Year Assets Growth
2006 359.753.006
2007 527.632.944 31.82%
2008 979.866.943 46.15%
2009 1.188.522.431 17.56%
2010 1.665.564.867 28.64%
2011 1.799.573.516 7.45%
2012 2.122.132.772 15.2%
2013 2.292.152.804 7.42%
2014 2.445.434.166 6.27%
2015 2.654.368.775 7.87%
2016 2.793.612.820 4.98%
2017 3.847.865.609 27.4%
2018 3.834.468.144 -0.35%
2019 3.648.221.000 -5.11%
2020 3.040.929.000 -19.97%
2021 3.213.662.000 5.37%
2022 5.056.204.000 36.44%
2023 5.062.728.000 0.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Genesys International Corporation Limited Liabilities
Year Liabilities Growth
2006 99.381.542
2007 151.999.745 34.62%
2008 275.947.388 44.92%
2009 200.225.153 -37.82%
2010 256.746.364 22.01%
2011 245.667.034 -4.51%
2012 370.743.461 33.74%
2013 276.770.969 -33.95%
2014 363.400.333 23.84%
2015 512.681.330 29.12%
2016 510.755.978 -0.38%
2017 654.290.255 21.94%
2018 678.264.449 3.53%
2019 586.965.000 -15.55%
2020 491.618.000 -19.39%
2021 854.935.000 42.5%
2022 981.336.000 12.88%
2023 1.039.319.000 5.58%

Genesys International Corporation Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
44.65
Net Income per Share
0.37
Price to Earning Ratio
1367.58x
Price To Sales Ratio
11.19x
POCF Ratio
702.63
PFCF Ratio
703.19
Price to Book Ratio
4.71
EV to Sales
11.38
EV Over EBITDA
35.31
EV to Operating CashFlow
715.34
EV to FreeCashFlow
715.34
Earnings Yield
0
FreeCashFlow Yield
0
Market Cap
18,89 Bil.
Enterprise Value
19,22 Bil.
Graham Number
29.5
Graham NetNet
0.73

Income Statement Metrics

Net Income per Share
0.37
Income Quality
0.28
ROE
0.01
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.5
EBT Per Ebit
0.99
Ebit per Revenue
0.11
Effective Tax Rate
0.53

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.38
Operating Profit Margin
0.11
Pretax Profit Margin
0.11
Net Profit Margin
0.05

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.71
Free CashFlow per Share
0.71
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
109.86
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
3.32
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
28,22
Book Value per Share
105,94
Tangible Book Value per Share
58.68
Shareholders Equity per Share
105.94
Interest Debt per Share
10.15
Debt to Equity
0.09
Debt to Assets
0.07
Net Debt to EBITDA
0.6
Current Ratio
2.82
Tangible Asset Value
2,22 Bil.
Net Current Asset Value
1,04 Bil.
Invested Capital
0.09
Working Capital
1,34 Bil.
Intangibles to Total Assets
0.36
Average Receivables
0,00 Bil.
Average Payables
0,15 Bil.
Average Inventory
0
Debt to Market Cap
0.02

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Genesys International Corporation Limited Dividends
Year Dividends Growth
2003 1
2008 2 50%
2009 2 0%
2010 2 -100%
2011 1 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%

Genesys International Corporation Limited Profile

About Genesys International Corporation Limited

Genesys International Corporation Limited provides mapping, survey, and geospatial services worldwide. The company offers aerial and digital photogrammetry services, such as aerial imagery acquisition-UAV/drone and aircraft, photogrammetric film scanning, stereo-compilation, aerial triangulation and adjustment, DEM/DTM, contouring and cross-section, 3D building and structure modelling, orthorectification, and 3D data migration and GIS-ready format services. It also provides aerial, mobile, and terrestrial LiDAR services; geospatial services, such as data capture, conversion, processing, integration, maintenance, and update; 2D and 3D mapping services; and application development services, including enterprise GIS and web-based application, mobile app development, and system integration services for public and private enterprises, and consumers. In addition, the company offers building information modeling services; and business consulting services, including requirement analysis, project design and planning, project management, GIS orientation seminar and workshop, and database and application design with system configuration. Further, it provides various solutions, such as TeleSCAPE InfraSCAPE, CitySCAPE, WaterSCAPE, market analysis and route planning system, and WoNoBo solutions. The company provides its services to the urban development, utility, infrastructure, navigation, natural resource, and disaster management industries. Genesys International Corporation Limited was incorporated in 1983 and is headquartered in Mumbai, India.

CEO
Mr. Sajid Malik ACA, B.Com.
Employee
1.050
Address
73-A SDF III
Mumbai, 400096

Genesys International Corporation Limited Executives & BODs

Genesys International Corporation Limited Executives & BODs
# Name Age
1 Mr. Ravi Kumar V. Jatavallabha
Senior Vice President of Corporate Strategy & Chief Financial Officer
70
2 Mr. Vineet Chopra
Vice President of Legal & Company Secretary
70
3 Mr. Sajid Malik ACA, B.Com.
Chairman & MD
70

Genesys International Corporation Limited Competitors